Loading Events
Find Events

Event Views Navigation

Upcoming Events › Grant

Events List Navigation

July 2017

Cycle 3: Alzheimer’s Drug Discovery Foundation

July 31

LOI DUE JULY 31, 2017
Preclinical Drug Discovery
Seeks to fund promising preclinical drug discovery and biomarker development programs for Alzheimer’s disease, related dementias and cognitive aging. The ADDF typically supports one year of research at a time, with potential for future follow-on funding. Funding can range from $150,000-$600,000 for a preclinical project.
Program to Accelerate Clinical Trials (PACT)
Seeks to fund biomarker-based, proof-of-concept pilot clinical trials, as well as Phase 1 safety testing and IND-enabling studies to accelerate new drugs into trials. Up to $1.5 million.
Biomarkers Development
Seeks to support the development and validation of novel and existing biomarkers that will enhance the design and performance of clinical trials for Alzheimer’s disease, related dementias, and cognitive aging. $150,000-$300,000/year, 1-2 years.
Prevention Beyond the Pipeline
The ADDF seeks to support prevention drug discovery not covered by most research funders or our current RFPs. Funding can range from $50,000-$100,000 for epidemiological analyses, $150,000-$600,000 for preclinical research, and up to $1.5 million for clinical trials.
Accelerating Drug Discovery for Frontotemporal Degeneration
Seeks to accelerate and support innovative drug discovery programs for FTD in partnership with The Association for Frontotemporal Degeneration. Funding can range from $100,000-$150,000 per year, average one year duration.

Find out more »
August 2017

Foundation for Physical Therapy

August 3

DUE AUGUST 3, 2017, NOON EDT
Foundation Research Grant
Funds clinically relevant research by emerging investigators seeking to evaluate the effectiveness of physical therapy interventions. This grant will provide $40,000 for either one or two year projects.
Snyder Research Grant
One $40,000 SRG is to be awarded to support relevant clinical research projects aimed to investigate: a) those services delivered by physical therapists; and b) the development of new interventions that offer reasonable assurance that they will be clinically relevant and therapeutically effective.

Find out more »

Cycle 2: Ruth L. Kirschstein National Research Service Awards (F Series)

August 8

Sponsor: National Institutes of Health
Due Date: August 8, 2017
Award: Fellowship

Find out more »

Cycle 2: Conference Grants (R13) and Conference Cooperative Agreements (U13)

August 12

Sponsor: NIH
Due Date: August 12, 2017
Award: Funding for conferences

Find out more »
September 2017

Cycle 1: BRAIN Initiative: Development, Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (STTR)(R41/R42)

September 5

Sponsor: National Institutes of Health
Due Date: September 5, 2017 by 5 pm local time of applicant
Award: Total funding support (direct costs, indirect costs, fee) normally may not exceed $150,000 for Phase I awards and $1,000,000 for Phase II awards. With appropriate justification from the applicant, Congress will allow awards to exceed these amounts by up to 50 percent ($225,000 for Phase I and $1,500,000 for Phase II).

Find out more »

Cycle 1: BRAIN Initiative: Development, Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (SBIR)(R43/R44)

September 5

Sponsor: National Institutes of Health
Due Date: September 5, 2017 by 5 pm local time of applicant
Award: Total funding support (direct costs, indirect costs, fee) normally may not exceed $150,000 for Phase I awards and $1,000,000 for Phase II awards. With appropriate justification from the applicant, Congress will allow awards to exceed these amounts by up to 50 percent ($225,000 for Phase I and $1,500,000 for Phase II).

Find out more »

Cycle 1: Development of Novel and Emerging Technologies to Support Zebrafish Models for Biomedical Research (R43/R44)

September 5

Sponsor: National Institutes of Health
Due Date: September 5, 2017 by 5 pm local time of applicant
Award: Money, property, or both to an eligible entity to carry out an approved project or activity. Total funding support (direct costs, indirect costs, fee) normally may not exceed $150,000 for Phase I awards and $1,000,000 for Phase II awards. With appropriate justification from the applicant, Congress will allow awards to exceed these amounts by up to 50 percent ($225,000 for Phase I and $1,500,000 for Phase II).

Find out more »

Cycle 1: Development of Novel and Emerging Technologies to Support Zebrafish Models for Biomedical Research (R41/R42)

September 5

Sponsor: National Institutes of Health
Due Date: September 5, 2017 by 5 pm local time of applicant
Award: Money, property, or both to an eligible entity to carry out an approved project or activity. Total funding support (direct costs, indirect costs, fee) normally may not exceed $150,000 for Phase I awards and $1,000,000 for Phase II awards. With appropriate justification from the applicant, Congress will allow awards to exceed these amounts by up to 50 percent ($225,000 for Phase I and $1,500,000 for Phase II).

Find out more »

Cycle 3: Preclinical Research on Model Organisms to Predict Treatment Outcomes for Disorders Associated with Intellectual and Developmental Disabilities (R01)

September 5

Sponsor: NIH
LOI Due Date: September 5, 2017
Due Date: October 5, 201 by 5 pm local time of applicant
Award: Budgets for direct costs of up to $499,999 per year may be requested. Project period may not exceed 5 years.

Find out more »

Cycle 3: High Throughput Screening (HTS) to Discover Chemical Probes (R01)

September 5

Sponsor: National Institutes of Health
LOI Due Date: September 5, 2017
Application Due Date: October 5, 2017
Award: Actual needs 3 years

Find out more »

Cycle 1: Small Business Innovation Research (SBIR)

September 5

Sponsor: National Institutes of Health
Due Date: September 5, 2017
Award: Total costs for Phase I and Phase II usually do not exceed $1,150,000; no funding is provided for Phase III

Find out more »

Cycle 1: Small Business Technology Transfer (STTR)

September 5

Sponsor: National Institutes of Health
Due Date: September 5, 2017
Award: Total costs for Phase I and Phase II usually do not exceed $1,150,000; no funding is provided for Phase III

Find out more »

AES Seed Grant Program 

September 22

Sponsor: American Epilepsy Society
Due Date: September 22, 2017
Award: Seed Grants may provide up to $20,000 for one year for direct costs only, and they may not be renewed. Examples of allowable costs include research project supplies and expenses related to information and technology exchange, such as travel for postdoctoral fellows between collaborating laboratories. The number of awards made each year is contingent on available funds.

Find out more »

AES Seed Grant Program 

September 22

Sponsor: American Epilepsy Society
Due Date: September 22, 2017
Award: The AES Seed Grant Program provides support to established investigators to pursue new and innovative directions in epilepsy research, bring new research methods to their research programs, or begin new collaborations with other investigators in epilepsy or in different, complementary disciplines. Seed Grants may provide up to $20,000 for one year for direct costs only, and they may not be renewed.

Find out more »

Cycle 3: The Midlife in the United States Study (U19)

September 25

Sponsor: National Institutes of Health
Due Date: September 25, 2017 by 5 pm local time of applicant organization
Award: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications. Application budgets are not limited but need to reflect the actual needs of the proposed project. The maximum project period is 5 years.

Find out more »

Cycle 3: Ruth L. Kirschstein National Research Service Awards (T Series)

September 25

Sponsor: National Institutes of Health
Due Date: September 25, 2017
Award: Training grants

Find out more »
October 2017

Gairdner International Awards

October 1

Sponsor: Gairdner Foundation
Nomination Due Date: October 1, 2017
Award: Seven awards of $100,000 Canadian

Find out more »

Cycle 3: Whitehall Foundation Grants-in-Aids

October 1

Sponsor: Whitehall Foundation, Inc.
LOI Due Date: October 1, 2017
Application Due Date: February 15, 2018
Award: $30,000 for one year.

Find out more »

Cycle 3: Whitehall Foundation Research Grants

October 1

Sponsor: Whitehall Foundation, Inc.
LOI Due Date: October 1, 2017
Application Due Date: February 15, 2018
Award: Research grants normally range from $30,000 to $75,000 per year for up to three years.

Find out more »

Career Awards for Medical Scientists

October 3

Sponsor: Burroughs Wellcome Fund
Due Date: October 3, 2017 by 4:00pm EDT
Award: These awards are targeted toward medically trained individuals whose research proposal is in basic biomedical, disease-oriented, translational, or molecular, genetic, or pharmacological epidemiology research, and who intend to pursue careers in academia. $700,000 awards over five years for physician-scientists.

Find out more »
+ Export Events